MRL Pertuzumab and trastuzumab / MRL Trastuzumab/pertuzumab 600 mg/1200 mg, rochin for in ̆ ̆ ̆ ̆ ̆ ̆ 15 ml; Trastuzumab/pertuzumab 600 mg/600 mg, rochin for in ̆ ̆ ̆ ̆ ̆ 10 ml by code DC 021:2015: 33600000-6 Pharmaceutical products (DC 021:2015: 33650000-1 Order anti-infectious agents for systemic use, vaccines, anti-neoplastic agents and immunomodulators)
- 采购方
- prozorro_gov_ua
- 机构全称
- COMUNAL NECOMERCY PIDPRIEMSTVO " HERSONSKI REGIONALNALNAL ONCOLOGIC CENTER " has been established by the HERSONSKI RADY
- 国家/地区
- Ukraine
- 截止时间
- 2026-11-04
- 发布时间
- 2026-10-29
- 公告编号
- UA-2026-10-29-012697-a
- 预算/金额
- 24308.78
- 来源编号
- PROZORRO-UA-2026-10-29-012697-a
公告概况
Trastuzumab: Classification according to MRL: Pertuzumab and trastuzumab, Classification according to ATH: L01XY02, Form of release: Rozchin for in `єкцій, Dose of active substance: 1200 mg/600 mg, Type of packaging: Flacon, Volume: 15 ml; Classification according to MRL: Pertuzumab and trastuzumab,
查看完整公告
完整描述、联系方式与采购文件需登录后查看。